Backed iVEAcare's launch with $27.5M in Series A funding.
iVEAcare is a medical technology company dedicated to advancing the science and clinical application of vagus nerve stimulation (VNS) for individuals living with epilepsy
iVEAcare is a medical technology company dedicated to advancing the science and clinical application of vagus nerve stimulation (VNS) for individuals living with epilepsy. We are focused on developing innovative neuromodulation technologies with the potential to improve the lives of patients and families affected by neurological disorders.